Food and Medication Administration . Regorafenib can be an investigational agent and isn’t accepted by the FDA, the European Medicines Company or other Wellness Authorities. That is an important part of the entire development process because of this investigational substance, stated Kemal Malik, MD, Head of Global Development and person in the Bayer Health care Executive Committee. Related StoriesSurgical startup seeks financing to build digital reality training libraryAddressing standard of living needs in prostate tumor: an interview with Professor Louis DenisOJ Bio at Medica 2015 – Stage of Care diagnostics' part in reducing antibiotics prescribingIn January, Bayer began enrolling sufferers in a randomized, double-blind, placebo-controlled Stage III research of regorafenib plus greatest supportive caution versus placebo plus greatest supportive care for topics with metastatic and/or unresectable gastrointestinal stromal tumors whose disease provides progressed despite prior treatment with at least imatinib and sunitinib .Hospitals, insurer join forces to make new health system Some say the move, which will include UCLA Health insurance and Cedars-Sinai, is targeted at Kaiser Permanente and is being made to hold down wellness costs. The New York Situations: Hospitals And Insurer GET TOGETHER In California In a partnership that are the first of its kind, Anthem Blue Cross, a large California health insurance firm, is normally teaming up with seven fiercely competitive medical center groups to make a new health program in the LA area. The partnership contains such well-known medical centers as UCLA Health insurance and Cedars-Sinai . Related StoriesFirst medical center installs Ortho Vision AnalyzerPatients offered animal-assisted therapy at UCLA HealthHeart of the Rockies Regional INFIRMARY selects Aprima EHRLos Angeles Occasions: New Anthem Blue Cross Plan ASSUMES Kaiser Taking aim at HMO huge Kaiser Permanente, insurer Anthem Blue Cross is becoming a member of forces with several big-name hospitals and their doctors to generate a unique health plan choice for employers in Southern California.